RxDoctor Payments Data

Steven Greenberg, MD

Neurology · Boston, MANPI 1508847310

Payments from drug & device makers

$46,246in general payments, 2019–2025

Across 18 payments — averaging $2569.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$31K
  • Bayer$7K
  • E.r. Squibb & Sons, L.L.C.$7K
  • Lilly USA, LLC$1K
  • Eli Lilly$625

What the payments were for

  • Consulting fees$44,87997%
  • Food & beverage$1870%
  • Education$1,1803%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$46,246 in reported general payments places this provider in the 75th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$35,920
Medicare patients
133
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban15$13,107
Memantine Hcl25$1,936
Minocycline Hcl15$457
Levetiracetam13$438

Paid to pharmacies, not to this prescriber.

Other neurology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →